The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
Monoclonal antibodies lead biosimilar approvals because of their large market size, well-defined regulatory pathways, and ...
A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
News-Medical.Net on MSN2d
New monoclonal antibody shows promise in treating mucormycosisMucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of ...
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...
Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval
On , US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical-an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback